Drugs / SHAPE Gel
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02636244 | Feb → Aug 2017 | alopecia areata | TetraLogic Pharmaceuticals | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SHAPE Gel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02636244 ↗ |
| Action | Inhibit | “a Histone Deacetylase Inhibitor” NCT02636244 ↗ |
| Route | Topical | “SHAPE Gel applied topically to adult patients with alopecia areata of the scalp” NCT02636244 ↗ |